No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr1:184180200-184194400 |
Weak transcription |
Fetal Brain Male |
brain
|
2 |
chr1:184182400-184193400 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin03 |
Skin
|
3 |
chr1:184182400-184195400 |
Weak transcription |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
4 |
chr1:184191800-184192400 |
Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
5 |
chr1:184191800-184192400 |
Active TSS |
Pancreatic Islets |
Pancreatic Islet
|
6 |
chr1:184191800-184192400 |
Flanking Active TSS |
Skeletal Muscle Male |
skeletal muscle
|
7 |
chr1:184191800-184192800 |
Active TSS |
Brain Dorsolateral Prefrontal Cortex |
brain
|
8 |
chr1:184191800-184192800 |
Active TSS |
A549 |
lung
|
9 |
chr1:184191800-184194600 |
Weak transcription |
Fetal Brain Female |
brain
|
10 |
chr1:184192000-184192400 |
Flanking Bivalent TSS/Enh |
ES-I3 Cell Line |
embryonic stem cell
|
11 |
chr1:184192000-184192400 |
Bivalent/Poised TSS |
ES-WA7 Cell Line |
embryonic stem cell
|
12 |
chr1:184192000-184192400 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
13 |
chr1:184192000-184192400 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
14 |
chr1:184192000-184192800 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
15 |
chr1:184192200-184192400 |
Bivalent/Poised TSS |
iPS-15b Cell Line |
embryonic stem cell
|
16 |
chr1:184192200-184192400 |
Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
17 |
chr1:184192200-184192400 |
Enhancers |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
18 |
chr1:184192200-184192400 |
Active TSS |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
19 |
chr1:184192200-184192600 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
20 |
chr1:184192200-184192800 |
Bivalent/Poised TSS |
HUES6 Cell Line |
embryonic stem cell
|
21 |
chr1:184192200-184194600 |
Weak transcription |
Brain Substantia Nigra |
brain
|